Advisory Services Network’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Advisory Services Network’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-500	Closed	-$2K	–	3109
2020 Q1	$2K	Hold	500	–	–	﹤0.01%	2827
2019 Q4	$3K	Hold	500	–	–	﹤0.01%	2815
2019 Q3	$3K	Hold	500	–	–	﹤0.01%	2600
2019 Q2	$3K	Buy	+500	New	+$2.41K	﹤0.01%	2598
2019 Q1	–	Sell	-500	Closed	-$2K	–	2780
2018 Q4	$2K	Hold	500	–	–	﹤0.01%	2358
2018 Q3	$3K	Buy	+500	New	+$3.84K	﹤0.01%	2265
2017 Q2	–	Sell	-22,825	Closed	-$215K	–	2412
2017 Q1	$215K	Buy	+22,825	New	+$228K	0.03%	580

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Advisory Services Network's PGNX Position: Q2 2020 in Review

Advisory Services Network sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 500 shares — an estimated $2K sold.

Advisory Services Network first reported a position in PGNX in Q1 2017 and held it in 7 quarters. The position peaked at $215K in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Advisory Services Network reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Advisory Services Network sold 500 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $2K.
Advisory Services Network first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 7 quarters.
Advisory Services Network's Progenics Pharmaceuticals Inc position peaked at $215K in Q1 2017.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Advisory Services Network's 13F filing for Q2 2020, filed 10 Aug 2020.